Outset Medical, Inc. (OM) Reports Q3 Loss, Lags Revenue Estimates

Core Insights - Outset Medical, Inc. reported a quarterly loss of $0.69 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.64, marking an earnings surprise of -7.81% [1] - The company's revenues for the quarter ended September 2025 were $29.43 million, missing the Zacks Consensus Estimate by 3.19%, but showing an increase from $28.67 million year-over-year [2] - Outset Medical shares have declined approximately 27.5% year-to-date, contrasting with the S&P 500's gain of 14.4% [3] Financial Performance - Over the last four quarters, Outset Medical has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] - The current consensus EPS estimate for the upcoming quarter is -$0.54 on revenues of $32.4 million, and for the current fiscal year, it is -$3.96 on revenues of $124 million [7] Market Outlook - The company's stock performance in the near future is expected to align with the market, as indicated by a Zacks Rank 3 (Hold) [6] - The outlook for the Medical Info Systems industry, where Outset Medical operates, is relatively strong, ranking in the top 27% of over 250 Zacks industries [8]